Overview

Treatment of Psoriasis With Parathyroid Hormone

Status:
Completed

Trial end date:
2005-04-01

Target enrollment:
0

Participant gender:
All

Summary

This is a clinical study in two phases. The first phase compares the effect of an ointment containing parathyroid hormone (PTH) with the effect of a placebo ointment (inactive ointment without PTH) on psoriasis lesions. Neither the study participants nor the researchers will know who is receiving PTH ointment and who is receiving placebo until the end of this first study phase. The second phase is a study of the PTH ointment on large areas of psoriasis to find out how long the effects last.

Phase:

Phase 1/Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Treatments:

Hormones
Parathyroid Hormone

Criteria

Inclusion Criteria:

- Active plaque psoriasis at least 10 percent BSA (body surface area)

- Age 18-70

Exclusion Criteria:

- Abnormalities of calcium metabolism